Last reviewed · How we verify
AVT05
At a glance
| Generic name | AVT05 |
|---|---|
| Sponsor | Alvotech Swiss AG |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants (PHASE1)
- Comparative, Multicenter Study in Subjects with Rheumatoid Arthritis, ALVOFLEX (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AVT05 CI brief — competitive landscape report
- AVT05 updates RSS · CI watch RSS
- Alvotech Swiss AG portfolio CI